<DOC>
	<DOCNO>NCT00158925</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness EASYTRAK EPI lead .</brief_summary>
	<brief_title>The EASYTRAK EPI Clinical Investigation</brief_title>
	<detailed_description>This prospective , single-armed , multi-center U.S. , Australian , Canadian , European clinical investigation , design demonstrate safety effectiveness EASYTRAK EPI lead human .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Patients meet EASYTRAK EPI indication Patients age 18 , legal age give inform consent specific state national law Patients willing capable providing informed consent , undergoing device implant , participate test associate clinical investigation approve clinical investigational center interval define protocol Patients meet one follow three condition : Meet current indication cardiac resynchronization therapy ( CRT ) epicardial placement pace/sense lead leave ventricle prefer endocardial lead Meet current indication cardiac pace system document evidence endocardial lead use Meet current indication cardiac pace system concurrent cardiac surgical procedure take place additional surgical procedure require provide access epicardial surface heart Patients meet EASYTRAK EPI contraindication Patients myocardial infarct , unstable angina , percutaneous coronary intervention precede 30 day prior enrollment Patients document life expectancy le 6 month expect undergo heart transplant within next 6 month Patients enrol concurrent study , without Guidant write approval , may confound result study Women pregnant plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Artificial Cardiac Pacing</keyword>
	<keyword>Implanted Electrodes</keyword>
</DOC>